Opus Genetics (IRD) EBIT Margin (2010 - 2026)
Opus Genetics (IRD) posted EBIT Margin of -2182.78% for Q2 2026, down 1873.76 percentage points from -309.02% a year earlier and down 1516.86 percentage points from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) EBIT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Opus Genetics was -513.47%, down 92.79 percentage points year-over-year; for FY2025, it came in at -271.90%, up 292.82 percentage points from FY2024.
- Annual EBIT Margin shows a four-year change of +3582.94 percentage points (FY2021 to FY2025).
- In prior years, Opus Genetics' EBIT Margin was -564.72% in FY2024 (-509.27 pp), -55.45% in FY2023 (-101.19 pp), 45.74% in FY2022 (+3900.58 pp) and -3854.84% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBIT Margin since Q2 2021.
- On a year-over-year basis, EBIT Margin increased in three of the last eight quarters, with an average year-over-year change of -243.50 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2025, with a gain of 587.66 percentage points; the weakest was Q2 2026, with a drop of 1873.76 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -665.92% (Q1 2026), -296.33% (Q4 2025) and -269.93% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Opus Genetics | 409.11 Mn | 184.39 Mn | - | -2,182.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,182.78% |
| Mar 31, 2026 | -665.92% |
| Dec 31, 2025 | -296.33% |
| Sep 30, 2025 | -269.93% |
| Jun 30, 2025 | -309.02% |
| Mar 31, 2025 | -227.21% |
| Dec 31, 2024 | -883.98% |
| Sep 30, 2024 | -207.11% |
| Jun 30, 2024 | -748.92% |
| Mar 31, 2024 | -450.50% |
| Dec 31, 2023 | -321.05% |
| Sep 30, 2023 | 53.51% |
| Jun 30, 2023 | -146.68% |
| Mar 31, 2023 | -350.54% |
| Dec 31, 2022 | 85.85% |
| Sep 30, 2021 | -865.44% |
| Jun 30, 2021 | -7,137.00% |
| Mar 31, 2020 | -237.83% |
| Jun 30, 2010 | -17,008.07% |
API Access
Opus Genetics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();